Recently, Stryker (SYK) announced its intent to purchase MAKO Surgical (MAKO) for $1.65 billion, sending shares to nearly $30 after holding the mid- to low-teens for nearly a year.
Did this surprise us?
Not at all. In fact, on May 30, 2012 as a part of a huge video presentation we published, Mike Stathis went over his short- intermediate- and longer-term forecast for shares of MAKO.
As you might have suspected, he was spot on.
Take a look at the video below.
In the spring of 2012, we released 2 landmark video series which was led by Mike Stathis.
The first was entitled "Fundamental and Technical Analysis of 20 Stocks Trading Over $100." Click here for more information.
The second was "60 Securities Poised for Huge Moves." Click here for more information.
Below are some followup articles discussing the performance of these securities based on the guidance provided in the video presentations.
Video Presentation Highlights:
[1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12]
What is the lesson to be learned?
You'd better get your hands on EVERYTHING Mike publishes, especially a video series like this.
We dropped the price of each series by about 50% (from $699 to $399/ newsletter subscribers; $899 to $449/general public) several months after it was released to account for some erosion in value. See here.
We are offering this combined presentation package (both video presentations) representing more than 15 hours of video content by Mike Stathis for an additional 50% off of the discounted price we posted back in the fall of 2012.*
Members & Newsletter Subscribers Pay Only $199
General Public Pays Only $225
Email us for payment arrangements.
*You will have access to these videos for at least 12 months.
Restrictions Against Reproduction: No part of this publication may be reproduced, stored in a retrieval system, or transmitted in any form or by any means, electronic, mechanical, photocopying, recording, scanning, or otherwise, except as permitted under Section 107 or 108 of the 1976 United States Copyright Act, without the prior written permission of the copyright owner and the Publisher.
These articles and commentaries cannot be reposted or used in any publications for which there is any revenue generated directly or indirectly. These articles cannot be used to enhance the viewer appeal of any website, including any ad revenue on the website, other than those sites for which specific written permission has been granted. Any such violations are unlawful and violators will be prosecuted in accordance with these laws.
Article 19 of the United Nations' Universal Declaration of Human Rights: Everyone has the right to freedom of opinion and expression; this right includes freedom to hold opinions without interference and to seek, receive and impart information and ideas through any media and regardless of frontiers.
This publication (written, audio and video) represents the commentary and/or criticisms from Mike Stathis or other individuals affiliated with Mike Stathis or AVA Investment Analytics (referred to hereafter as the “author”). Therefore, the commentary and/or criticisms only serve as an opinion and therefore should not be taken to be factual representations, regardless of what might be stated in these commentaries/criticisms. There is always a possibility that the author has made one or more unintentional errors, misspoke, misinterpreted information, and/or excluded information which might have altered the commentary and/or criticisms. Hence, you are advised to conduct your own independent investigations so that you can form your own conclusions. We encourage the public to contact us if we have made any errors in statements or assumptions. We also encourage the public to contact us if we have left out relevant information which might alter our conclusions. We cannot promise a response, but we will consider all valid information.